Premium
A novel homozygous mutation in the second transmembrane domain of the gonadotrophin releasing hormone receptor gene
Author(s) -
Söderlund D.,
Canto P.,
De La Chesnaye E.,
UlloaAguirre A.,
Méndez J. P.
Publication year - 2001
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1046/j.1365-2265.2001.01211.x
Subject(s) - hypogonadotrophic hypogonadism , genetics , mutation , biology , missense mutation , compound heterozygosity , exon , gene , endocrinology , hypogonadotropic hypogonadism , medicine , hormone
BACKGROUND and OBJECTIVE Mutations in the GnRH receptor (GnRH‐R) gene cause hypogonadotrophic hypogonadism. Here, we present the molecular studies of the GnRH‐R gene in three families with isolated hypogonadotrophic hypogonadism. PATIENTS Three unrelated families, with at least two members diagnosed with isolated hypogonadotrophic hypogonadism were included. MEASUREMENTS DNA sequencing was performed after polymerase chain reaction amplification of each of the three exons of the gene. RESULTS A novel homozygous missense mutation, at nucleotide 268, turning glutamic acid into lysine, located at the second transmembrane domain of the GnRH‐R gene was found in two patients pertaining to one of the families studied. Both parents and an unaffected brother were heterozygous carriers of one mutant allele, an unaffected sister was homozygote wild type. In the other two affected families no mutations were found in the GnRH‐R gene. CONCLUSIONS This constitutes the first description of an spontaneous mutation located at the second transmembrane domain (Glu90Lys) of the GnRH‐R, indicating that the integrity of glutamic acid at this position is crucial for receptor function. Also this report, complementing others, demonstrates that mutations are distributed throughout the GnRH‐R gene and that as in the only other homozygous mutation previously described, affected patients present a complete form of hypogonadotrophic hypogonadism. Due to the fact that apparently consanguinity was present in our affected family, we presume that the mutation derived from a common ancestor, by a founder gene effect.